Cargando…
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer
Programmed death ligand 1 (PD-L1) expression is a predictive biomarker of the success of PD-1/PD-L1 inhibitor therapy for patients with advanced non-small cell lung cancer (NSCLC) but its role as a prognostic marker for early stage resectable NSCLC remains unclear. Here, we studied PD-L1 expression...
Autores principales: | Lin, Gen, Fan, Xirong, Zhu, Weifeng, Huang, Cheng, Zhuang, Wu, Xu, Haipeng, Lin, Xiandong, Hu, Dan, Huang, Yunjian, Jiang, Kan, Miao, Qian, Li, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663570/ https://www.ncbi.nlm.nih.gov/pubmed/29137398 http://dx.doi.org/10.18632/oncotarget.20233 |
Ejemplares similares
-
Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer
por: Xu, Haipeng, et al.
Publicado: (2017) -
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
por: Ameratunga, Malaka, et al.
Publicado: (2016) -
Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer
por: Lin, Gen, et al.
Publicado: (2018) -
Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma
por: Lin, Zhi-qiang, et al.
Publicado: (2022) -
Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas
por: Takahara, Kento, et al.
Publicado: (2023)